These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 38729446)

  • 21. The relaxin gene-knockout mouse: a model of progressive fibrosis.
    Samuel CS; Zhao C; Bathgate RA; DU XJ; Summers RJ; Amento EP; Walker LL; McBurnie M; Zhao L; Tregear GW
    Ann N Y Acad Sci; 2005 May; 1041():173-81. PubMed ID: 15956703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo.
    Mardhian DF; Storm G; Bansal R; Prakash J
    J Control Release; 2018 Nov; 290():1-10. PubMed ID: 30287265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relaxin suppresses atrial fibrillation by reversing fibrosis and myocyte hypertrophy and increasing conduction velocity and sodium current in spontaneously hypertensive rat hearts.
    Parikh A; Patel D; McTiernan CF; Xiang W; Haney J; Yang L; Lin B; Kaplan AD; Bett GC; Rasmusson RL; Shroff SG; Schwartzman D; Salama G
    Circ Res; 2013 Jul; 113(3):313-21. PubMed ID: 23748429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.
    Zhou X; Chen X; Cai JJ; Chen LZ; Gong YS; Wang LX; Gao Z; Zhang HQ; Huang WJ; Zhou H
    Drug Des Devel Ther; 2015; 9():4599-611. PubMed ID: 26316699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relaxin and extracellular matrix remodeling: Mechanisms and signaling pathways.
    Ng HH; Shen M; Samuel CS; Schlossmann J; Bennett RG
    Mol Cell Endocrinol; 2019 May; 487():59-65. PubMed ID: 30660699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relaxin reduces susceptibility to post-infarct atrial fibrillation in mice due to anti-fibrotic and anti-inflammatory properties.
    Beiert T; Tiyerili V; Knappe V; Effelsberg V; Linhart M; Stöckigt F; Klein S; Schierwagen R; Trebicka J; Nickenig G; Schrickel JW; Andrié RP
    Biochem Biophys Res Commun; 2017 Aug; 490(3):643-649. PubMed ID: 28634079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Relaxin Expression from an Alginate Gel-Encapsulated Adenovirus on Scar Remodeling in a Pig Model.
    Yun IS; Kang E; Ahn HM; Kim YO; Rah DK; Roh TS; Lee WJ; Yun CO
    Yonsei Med J; 2019 Sep; 60(9):854-863. PubMed ID: 31433583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relaxin gene therapy: A promising new treatment option for various diseases with aberrant fibrosis or irregular angiogenesis.
    Hong J; Yun CO
    Mol Cell Endocrinol; 2019 May; 487():80-84. PubMed ID: 30641100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis.
    Samuel CS; Zhao C; Bathgate RA; Bond CP; Burton MD; Parry LJ; Summers RJ; Tang ML; Amento EP; Tregear GW
    FASEB J; 2003 Jan; 17(1):121-3. PubMed ID: 12424226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relaxin gene knockout mouse: a model of progressive scleroderma.
    Samuel CS; Zhao C; Yang Q; Wang H; Tian H; Tregear GW; Amento EP
    J Invest Dermatol; 2005 Oct; 125(4):692-9. PubMed ID: 16185267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy.
    Kim JH; Lee YS; Kim H; Huang JH; Yoon AR; Yun CO
    J Natl Cancer Inst; 2006 Oct; 98(20):1482-93. PubMed ID: 17047197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relaxin ameliorates salt-sensitive hypertension and renal fibrosis.
    Yoshida T; Kumagai H; Suzuki A; Kobayashi N; Ohkawa S; Odamaki M; Kohsaka T; Yamamoto T; Ikegaya N
    Nephrol Dial Transplant; 2012 Jun; 27(6):2190-7. PubMed ID: 22086971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relaxin-1-deficient mice develop an age-related progression of renal fibrosis.
    Samuel CS; Zhao C; Bond CP; Hewitson TD; Amento EP; Summers RJ
    Kidney Int; 2004 Jun; 65(6):2054-64. PubMed ID: 15149318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single adenovirus-mediated relaxin delivery attenuates established liver fibrosis in rats.
    Kim JK; Lee JI; Paik YH; Yun CO; Chang HY; Lee SY; Lee KS
    J Gene Med; 2016; 18(1-3):16-26. PubMed ID: 26769058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relaxin remodels fibrotic healing following myocardial infarction.
    Samuel CS; Cendrawan S; Gao XM; Ming Z; Zhao C; Kiriazis H; Xu Q; Tregear GW; Bathgate RA; Du XJ
    Lab Invest; 2011 May; 91(5):675-90. PubMed ID: 21221074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of relaxin on cardiac fibroblast-to-myofibroblast transition: an electrophysiological study.
    Squecco R; Sassoli C; Garella R; Chellini F; Idrizaj E; Nistri S; Formigli L; Bani D; Francini F
    Exp Physiol; 2015 Jun; 100(6):652-66. PubMed ID: 25786395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relaxin regulates collagen overproduction associated with experimental progressive renal fibrosis.
    Samuel CS; Mookerjee I; Masterson R; Tregear GW; Hewitson TD
    Ann N Y Acad Sci; 2005 May; 1041():182-4. PubMed ID: 15956704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis.
    Chow BS; Kocan M; Bosnyak S; Sarwar M; Wigg B; Jones ES; Widdop RE; Summers RJ; Bathgate RA; Hewitson TD; Samuel CS
    Kidney Int; 2014 Jul; 86(1):75-85. PubMed ID: 24429402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The involvement of the Wnt/β-catenin signaling cascade in fibrosis progression and its therapeutic targeting by relaxin.
    Somanader DVN; Zhao P; Widdop RE; Samuel CS
    Biochem Pharmacol; 2024 May; 223():116130. PubMed ID: 38490518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous relaxin regulates collagen deposition in an animal model of allergic airway disease.
    Mookerjee I; Solly NR; Royce SG; Tregear GW; Samuel CS; Tang ML
    Endocrinology; 2006 Feb; 147(2):754-61. PubMed ID: 16254028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.